Main menu


You are here

Situation Report

Poll: Number of Americans who plan to get vaccinated falls to 42% — a new low

So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time. 

But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective? 

“It’s not a vaccine that will save us,” says Harvard Global Health Institute director Ashish Jha. “It’s vaccination.” 

Problem, Solution, SitRep, or ?: 

TB, Malaria and H.I.V. are spreading amid the coronavirus pandemic

It begins with a mild fever and malaise, followed by a painful cough and shortness of breath. The infection prospers in crowds, spreading to people in close reach. Containing an outbreak requires contact tracing, as well as isolation and treatment of the sick for weeks or months.

This insidious disease has touched every part of the globe. It is tuberculosis, the biggest infectious-disease killer worldwide, claiming 1.5 million lives each year.

Problem, Solution, SitRep, or ?: 

Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.

The company recently began a clinical trial in Europe and the United States to test its vaccine in people. It is one of more than 30 human trials for coronavirus vaccines underway across the world. But until these trials are complete — which will probably take several months — the monkey data offers the best clues to whether the vaccines will work.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Situation Report
howdy folks
Page loaded in 1.318 seconds.